OptimizeRX Corp (NASDAQ: OPRX) has reported E.P.S. of $-0.17 for its third fiscal quarter (ending September 30) versus $-0.19 for the same period a year ago. This performance was $-0.21 short of the consensus estimate of $0.04. For the latest four quarters through September 30, E.P.S. were $-0.82 compared to $-0.58 a year ago.
Recent Price Action
OptimizeRX Corp (NASDAQ: OPRX) stock enjoyed a major increase of 15.3% on 11/6/23. The shares closed at $9.79. Relative to the market the stock has been extremely weak over the last nine months but has risen 28.0% during the last week.
Current PriceTarget Research Rating
OPRX is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
OptimizeRX has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. OptimizeRX has a poor Power Rating of 28 and a poor Appreciation Score of 20, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment